Skip to main content
. Author manuscript; available in PMC: 2013 Jan 22.
Published in final edited form as: J Intern Med. 2009 Jun;265(6):653–662. doi: 10.1111/j.1365-2796.2009.02100.x

Fig. 2.

Fig. 2

Proposed pathologic cascade from inflammation to fibrosis whereby maternal antibodies initiate events that lead to a persistent myofibroblast, a phenotype that is associated with scarring.

HHS Vulnerability Disclosure